Wordt geladen...
Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
Fidaxomicin was recently approved for the treatment of Clostridium difficile infection. It inhibits transcription by bacterial RNA polymerase. Because transcription is a multistep process, experiments were conducted in which fidaxomicin was added at different stages of transcriptional initiation to...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3388026/ https://ncbi.nlm.nih.gov/pubmed/22752861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis358 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|